MEDANTA

Global Health Limited

The Medanta hospital network — cardiac sciences, oncology and transplants

Healthcare›Healthcare›Healthcare Services›Hospital

medanta.org(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1240.00
Market cap
33,303 Cr
Stock P/E
59.9
P/B
8.41
Dividend yield
0.0%
ROE (FY26)
14.0%
ROCE (FY26)
15.3%
Operating margin (FY26)
15.8%
Debt / equity (FY26)
0.30
OCF / EBITDA (FY26)
77.7%
OCF / EBITDA (3Y)
75.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Medanta (Global Health) runs a network of six multi-specialty and super-specialty hospitals under the Medanta name, in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida.

Company snapshot

7thBy market cap

Ranked among 24 companies in Hospital.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales844 Cr833 Cr809 Cr861 Cr957 Cr943 Cr931 Cr1,031 Cr1,099 Cr1,121 Cr1,159 Cr1,304 Cr
Operating expenses (approx.)631 Cr621 Cr629 Cr675 Cr728 Cr706 Cr707 Cr804 Cr868 Cr904 Cr915 Cr1,017 Cr
EBITDA213 Cr212 Cr179 Cr186 Cr228 Cr238 Cr225 Cr227 Cr231 Cr217 Cr244 Cr287 Cr
OPM %25.2%25.5%22.2%21.6%23.9%25.2%24.1%22.0%21.0%19.4%21.0%22.0%
Other income21 Cr22 Cr27 Cr22 Cr18 Cr16 Cr23 Cr20 Cr20 Cr22 Cr37 Cr22 Cr
Interest20 Cr18 Cr18 Cr18 Cr16 Cr16 Cr15 Cr14 Cr17 Cr22 Cr27 Cr27 Cr
Depreciation43 Cr44 Cr45 Cr47 Cr49 Cr48 Cr49 Cr45 Cr50 Cr61 Cr67 Cr69 Cr
Profit before tax171 Cr172 Cr143 Cr144 Cr181 Cr189 Cr133 Cr208 Cr200 Cr120 Cr187 Cr213 Cr
Tax %26.6%28.3%11.0%26.0%27.8%24.4%24.0%23.6%20.7%20.7%24.4%26.3%
Net profit125 Cr124 Cr127 Cr106 Cr131 Cr143 Cr101 Cr159 Cr158 Cr95 Cr142 Cr157 Cr
EPS (₹)₹4.66₹4.61₹4.74₹3.96₹4.87₹5.32₹3.77₹5.92₹5.89₹3.54₹5.36₹5.91

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,500 Cr1,447 Cr2,167 Cr2,694 Cr3,275 Cr3,692 Cr4,410 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,314 Cr1,255 Cr1,716 Cr2,082 Cr2,476 Cr2,815 Cr3,491 CrSign in free for the trailing twelve months
EBITDA187 Cr191 Cr451 Cr612 Cr799 Cr877 Cr919 CrSign in free for the trailing twelve months
OPM %12.4%13.2%20.8%22.7%24.4%23.8%20.8%Sign in free for the trailing twelve months
Other income44 Cr31 Cr39 Cr65 Cr75 Cr79 Cr99 CrSign in free for the trailing twelve months
Interest52 Cr67 Cr79 Cr78 Cr74 Cr65 Cr79 CrSign in free for the trailing twelve months
Depreciation115 Cr123 Cr130 Cr150 Cr173 Cr194 Cr223 CrSign in free for the trailing twelve months
Profit before tax64 Cr32 Cr281 Cr449 Cr627 Cr647 Cr715 CrSign in free for the trailing twelve months
Tax %43.1%11.3%30.1%27.4%23.8%25.6%22.5%Sign in free for the trailing twelve months
Net profit36 Cr29 Cr196 Cr326 Cr478 Cr481 Cr554 CrSign in free for the trailing twelve months
EPS (₹)₹1.45₹1.15₹7.78₹12.58₹17.80₹17.92₹20.71Sign in free for the trailing twelve months
Dividend payout %———0.0%0.0%0.0%2.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital49 Cr50 Cr51 Cr54 Cr54 Cr54 Cr54 Cr
Reserves1,300 Cr1,333 Cr1,565 Cr2,375 Cr2,852 Cr3,333 Cr3,908 Cr
Borrowings622 Cr645 Cr838 Cr842 Cr419 Cr328 Cr1,190 Cr
Other liabilities695 Cr667 Cr692 Cr846 Cr979 Cr1,051 Cr731 Cr
Total liabilities2,666 Cr2,694 Cr3,146 Cr4,116 Cr4,304 Cr4,766 Cr5,905 Cr
Fixed assets (net)1,321 Cr1,259 Cr1,438 Cr1,708 Cr1,813 Cr1,975 Cr3,779 Cr
CWIP382 Cr464 Cr439 Cr327 Cr386 Cr529 Cr132 Cr
Investments—0.05 Cr0.05 Cr0.05 Cr0.05 Cr3 Cr3 Cr
Inventories39 Cr40 Cr53 Cr60 Cr67 Cr67 Cr79 Cr
Trade receivables149 Cr134 Cr180 Cr194 Cr215 Cr292 Cr411 Cr
Cash & bank148 Cr69 Cr119 Cr767 Cr425 Cr230 Cr127 Cr
Other assets629 Cr728 Cr915 Cr1,059 Cr1,398 Cr1,671 Cr1,374 Cr
Total assets2,666 Cr2,694 Cr3,146 Cr4,116 Cr4,304 Cr4,766 Cr5,905 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity175 Cr242 Cr311 Cr645 Cr612 Cr624 Cr714 Cr
Cash from investing-87 Cr-239 Cr-421 Cr-342 Cr-441 Cr-721 Cr-1,065 Cr
Cash from financing-0.88 Cr-81 Cr160 Cr346 Cr-514 Cr-97 Cr248 Cr
Net cash flow87 Cr-78 Cr50 Cr648 Cr-343 Cr-194 Cr-103 Cr
Free cash flow (OCF − Capex)-13 Cr96 Cr37 Cr409 Cr334 Cr107 Cr-124 Cr

Ratios

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %5.9%4.9%14.7%16.1%21.1%19.2%15.3%
ROE %2.7%2.1%12.1%13.4%16.5%14.2%14.0%
Debtor days36343026242934
Inventory days43423838353133
Days payable147140961249990100
Cash conversion cycle-67-64-28-59-40-30-33
OCF / EBITDA %93.8%126.3%69.1%105.3%76.6%71.1%77.7%
OCF / EBITDA % (3 years)——87.9%95.5%84.2%82.2%75.1%
Debt / equity0.460.470.520.350.140.100.30
Current ratio1.341.241.942.762.442.482.67
Net debt / EBITDA2.543.001.590.12-0.00660.111.16